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Head–head/tail–tail relative orientation of the pore-forming
domains of the heterodimeric ABC transporter TAP
Jan C. Vos, Eric A.J. Reits, Eldine Wojcik-Jacobs and Jacques Neefjes
Background: The transporter associated with antigen processing (TAP) is a
heterodimeric member of the large family of ABC transporters. The study of
interactions between the subunits TAP1 and TAP2 can reveal the relative
orientation of the transmembrane segments, which form a translocation pore
for peptides. This is essential for understanding the architecture of TAP and
other ABC transporters.
Results: The amino-terminal six transmembrane segments (TMs) of human
TAP1, TAP1(1–6), and the amino-terminal five TMs of TAP2, TAP2(1–5), are
thought to constitute the pore of TAP. Two new approaches are used to
define dimer interactions. We show that TM6 of TAP1(1–6) is able to change
topology post-translationally. This TM, along with a cytoplasmic tail, is
translocated into the endoplasmic reticulum lumen, unless TAP2 is
expressed. Coexpression of TM(4–5) of TAP2 stabilizes the topology of
TAP1(1–6), even when the TM1 of TAP1 is subsitituted with another
sequence. This suggests that the carboxy-terminal TMs of the pore-forming
domains TAP1(1–6) and TAP2(1–5) interact. An alternative assay uses
photobleaching in living cells using TAP1(1–6) tagged with the green
fluorescent protein (GFP). Coexpression with TAP2(1–5) results in reduced
movement of the heterodimer within the endoplasmic reticulum membrane,
as compared with the single TAP1(1–6) molecule. In contrast, TAP2(1–4)
has no effect on the mobility of TAP1(1–6)–GFP, indicating the importance
of TM5 of TAP2 for dimer formation. Also, TM1 of both TAP1 and TAP2 is
essential for formation of a complex with low mobility. 
Conclusions: Dimerization of the pore-forming transmembrane domains of
TAP1 (TM1–6) with its TAP2 counterpart (TM1–5) prevents the post-
translational translocation of TM6 of TAP1 and results in a complex with
reduced mobility within the endoplasmic reticulum membrane compared with
the free subunit. These techniques are used to show that the pore-forming
domains of TAP are aligned in a head–head/tail–tail orientation. This
positions the following peptide-binding segments of the two TAP subunits to
one side of the pore.
Background
ATP-binding cassette (ABC) transporters are a large family
of membrane proteins involved in the unidirectional
translocation of substrates across the lipid bilayer [1].
Eukaryotic ABC transporters are characterized by two
hydrophobic integral membrane domains of, usually, six
transmembrane segments (TMs) and two hydrophilic
nucleotide-binding domains, which provide the necessary
energy for the transport process. This set of domains is
either present in a single polypeptide chain or is assembled
from two protein subunits. ABC transporters are involved in
cystic fibrosis and also in multidrug resistance and antigen
presentation. Despite a large body of genetic and biochemi-
cal data, little is known about their inter- or intramolecular
interactions and the mechanism of active transport.
The transporter associated with antigen processing (TAP)
is a heterodimer of two related subunits [2–5] that deliv-
ers peptides from the cytosol into the endoplasmic reticu-
lum (ER) lumen. There, peptides associate with MHC
class I molecules and are transported to the cell surface.
In the absence of TAP, peptides originating in the
nuclear or cytoplasmic compartments do not reach the
cell surface and antigen presentation is impaired
(reviewed in [6]). In the ER, TAP forms a complex with
the chaperone protein tapasin and empty MHC class I
molecules. Viral proteins have been identified that specif-
ically block TAP function either by competing for
peptide binding at the cytosolic side of the ER mem-
brane or by inhibiting the transport step from the luminal
side (reviewed in [7]).
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We recently proposed a model for the membrane topolo-
gies of human TAP1 and TAP2 (Figure 1). We identified
an unusual number of TMs, and also a cytoplasmic sub-
strate-binding segment clearly set apart from the trans-
membrane pore and the nucleotide-binding domain [8].
The TAP1 subunit not only has a classical number of six
TMs for what is believed to be the transmembrane pore of
the transporter but, in addition, a pair of TMs that anchors
the cytoplasmic peptide-binding segment to the ER
membrane. In contrast, TAP2 contributes only five TMs
to the putative translocation pore and has its amino termi-
nus in the ER lumen. Like TAP1, the TAP2 peptide-
binding segment has an extra pair of TMs.
We have shown by co-immunoprecipitation studies that
the first six TMs of TAP1 are sufficient for dimerization
with TAP2 and that further carboxy-terminal truncation
abrogates stable binding to TAP2 [8]. This suggests that
the complete pore-forming domain of TAP1, consisting of
TM1 to TM6 (TM1–6), is necessary for a stable complex
with TAP2. We present here new strategies for defining
subunit interactions and especially their relative orienta-
tion. This is important for understanding the architecture
of TAP and has not been defined for any of the other ABC
transporters. We find that the topology of the TAP1 pore-
forming domain is stabilized by TAP2 in vivo. In its
absence, TM6 of TAP1(1–6) is translocated post-transla-
tionally into the lumen of the ER. Further dissection of the
process shows that TM(4–5) of TAP2 can inhibit the con-
version of TM6 of TAP1, independently of TM1 of TAP1.
This observation suggests an interaction between TM6 of
TAP1 and TM(4–5) of TAP2. Finally, using fusions with
the green fluorescent protein (GFP) for detection we show
that dimer interactions can alter the mobility of multispan-
ning integral membrane proteins in the ER membrane in
living cells. These experiments support the involvement
of TM1 of both TAP1 and TAP2 in dimerization. Our
data indicate that the transmembrane pore of TAP is
arranged in a head–head/tail–tail orientation, positioning
the peptide-binding pocket to one side of the pore.
Results
Influence of TAP2 on the topology of TAP1(1–6)
Topology of the TAP subunits was studied using TAP
subunit constructs truncated at the carboxy-terminal end
and fused to a reporter cassette [8]. This cassette contains
two potential N-linked glycosylation sites and a vesicular
stomatitis virus (VSV) epitope. The glycosylation status of
the chimeric protein reflects the intracellular localization
of the tail, as N-glycosylation occurs exclusively in the ER
lumen. The expression of TAP1(1–6) in transfected COS
cells results in proteins with different glycosylation status
(Figure 2a, lane 2). Although the reporter cassette contains
only two N-linked glycosylation sites, we detected three
bands in addition to the non-glycosylated form. This can
be explained by the presence of a third glycosylation con-
sensus sequence, which is situated at residues 227–229
immediately upstream of TM6 (residues 228–245) [2,8].
Although present in the ER lumen, this site is not glycosy-
lated when close to a TM [9]. Therefore, the glycosylation
of all three consensus sites at both sides of the TM can
only be explained by a complete luminal localization of
TM6. This argues against the membrane insertion of
TM6 in the opposite orientation. Unexpectedly, we found
that coexpression with TAP2(1–5), the counterpart of
TAP1(1–6), resulted in the appearance of the non-glycosy-
lated form of TAP1(1–6) only (Figure 2a, lane 3). This can
be explained in several ways, but all indicate a direct
interaction between TAP1(1–6) and TAP2(1–5). The
absence of glycosylation of TAP1(1–6) in the presence of
TAP2(1–5) might reflect localization of the carboxy-termi-
nal reporter sequence in the cytoplasm, or a block of gly-
cosylation due to steric hindrance by TAP2(1–5). Protease
protection assays (Figure 2b) show equal sensitivity of
TAP1(1–6) and TAP2(1–5) to trypsin digestion when both
subunits are coexpressed, suggesting that their carboxyl
termini are cytoplasmic (Figure 2b).
Whether glycosylation of TAP1(1–6) occurs co- or post-
translationally was examined by pulse-labeling cells trans-
fected with TAP1(1–6) for 15 minutes and chasing them
for various times. SDS–PAGE of immunoprecipitated
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Figure 1
Membrane topology model for the TAP1 (top) and TAP2 (bottom)
subunits of human TAP. TAP1 has eight transmembrane segments
(numbered TM1 to TM8), whereas TAP2 has only seven. TAP1(1–6)
and TAP2(1–5) consist of the amino-terminal six and five TMs,
respectively, and represent the pore-forming domains. The peptide-
binding domain is located between TM6 for TAP1 (or TM5 for TAP2)
and the nucleotide-binding domain (indicated as the ABC box).
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TAP1 species showed that the non-glycosylated forms
were converted with time into the glycosylated forms
(Figure 2c). Whereas glycosylation is considered to be a co-
translational event, this suggests post-translational translo-
cation of TM6 followed by glycosylation. Delayed
glycosylation could, however, be an alternative explanation.
In vitro translation was used to investigate this further.
TAP1(1–6) was synthesized in a reticulocyte lysate con-
taining canine microsomes, followed by a chase period in
phosphate-buffered saline (PBS). As in the in vivo situation,
the initial membrane insertion of TAP1(1–6) results in a
mainly non-glycosylated form, which converts into a glyco-
sylated form during the chase period following in vitro trans-
lation (Figure 2d, PBS), consistent with a post-translational
event. Washing the membranes before the chase period
with 10 mM EDTA in PBS to eliminate translation-arrested
ribosomes does not alter the outcome (data not shown). To
test whether the non-glycosylated initial product of
TAP1(1–6) has its carboxyl-terminus in the cytosol, an anti-
body against the VSV epitope at the extreme carboxyl ter-
minus of the protein was added during the chase period.
The anti-VSV antibody interferes with the appearance in
time of the glycosylated form, whereas a control antibody
(anti-Myc) has no effect. Thus, binding of the antibody at
the carboxyl terminus of a fully synthesized TAP1(1–6)
molecule at the cytosolic face of the membrane prevents its
post-translational translocation across the ER membrane.
We conclude that TAP1(1–6) is de novo inserted into the
membrane with its carboxyl terminus in the cytoplasm, as
indicated in Figure 1. In the absence of TAP2, TM6 is post-
translationally translocated into the ER lumen. Whether the
translocon is involved, as has been shown for retrograde
transport from the ER [10–12], remains to be determined.
Evidence for a tail–tail configuration of the TAP pore
The TMs of multi-spanning integral membrane molecules
are inserted into the membrane sequentially (reviewed in
[13]). Therefore, a plausible orientation of the two similar
halves of ABC transporters would be that the sixth TM of
the first half would line up with the first TM of the second
half (tail–head). Alternatively, the TMs of each subunit
could interact in a head–head/tail–tail configuration. We
used the post-translational conversion of the membrane
topology of TM6 of TAP1(1–6) as readout for association
with the pore-forming domain of TAP2. COS cells trans-
fected with TAP1(1–6) as well as similarly VSV-tagged
TAP2 constructs were analyzed by western blotting. As
shown above, TAP2(1–5) maintains TAP1(1–6) in the non-
glycosylated form, and this occurs in a dose-dependent
manner (Figure 3a). In contrast to TAP2(1–5), TAP2(1–3)
is not able to stabilize TAP1(1–6) in its original topology.
This suggests that TM4 and/or TM5 of TAP2 interact with
TM6 of TAP1. To confirm these observations, other com-
binations were tested (Figure 3b). We substituted TM1 of
TAP1 by an invariant chain (Ii) TM to investigate the role
of TM1 in the stabilization of TM6 by TAP2(1–5)
(Figure 3b, compare lanes 2 and 3). A similar result was
obtained as with TAP1(1–6), showing that TM1 of TAP1
is not essential for stabilization. Note that the
Ii–TAP1(2–6) construct has an additional glycosylation site
at residue 250 [2] compared with TAP1(1–6), because the
carboxy-terminal TAP1 amino acid in Ii–TAP1(2–6) is
His257 instead of Gly247 in TAP1(1–6). Again, coexpres-
sion of TAP2(4–5) is sufficient to prevent glycosylation
(Figure 3b, lane 5). This indicates a direct interaction
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Figure 2
Post-translational alteration of TAP1(1–6) topology. (a) TAP2(1–5)
influences the topology of TAP1(1–6). COS cells were transfected
with pTAP2(1–5) (lane 1), pTAP1(1–6) (lane 2) or a combination of
both (lane 3). Extracts were prepared after 48 h and VSV-tagged TAP1
and TAP2 derivatives analyzed by 12% SDS–PAGE. Proteins were
transferred to nitrocellulose and probed with anti-VSV antibodies.
Enhanced chemoluminescence (ECL) reactions were visualized by
autoradiography. The positions of the glycosylated and
non-glycosylated forms of TAP1(1–6) are indicated. (b) Protease
protection assay. COS cells were transfected with pTAP1(1–6) and
pTAP2(1–5) (top panel) or with pTAP1(1–6) alone (bottom panel).
Microsomes were prepared after 48 h and treated without trypsin
(lanes 1) or with 0.5 µg/ml (lanes 2), 1.5 µg/ml (lanes 3) or 5 µg/ml
(lanes 4) trypsin for 10 min at 20°C in PBS. The luminal ER protein
disulfide isomerase is not affected by trypsin under these conditions
(data not shown). Reaction products were analyzed as in (a). The
positions of TAP1(1–6) and TAP2(1–5) are indicated by arrows
(top panel), as well as the main glycosylated and non-glycosylated
TAP1(1–6) polypeptides (bottom panel). (c) Post-translational
glycosylation of TAP1(1–6). COS cells were transfected with
pTAP(1—6), pulse-labeled and chased for the times indicated. Proteins
were precipitated with anti-VSV antibodies, separated by 12%
SDS–PAGE and visualized by autoradiography. (d) In vitro
post-translational translocation of TM6 of pTAP1(1–6) is inhibited by
specific antibodies against the carboxyl terminus. TAP1(1–6) was
translated in a reticulocyte lysate in the presence of microsomes for
15 min. Isolated microsomes were chased in PBS at 30°C for the
times indicated in the absence (PBS) or presence of specific
(anti-VSV) or control (anti-Myc) antibodies. Proteins were separated by
12% SDS–PAGE and visualized by autoradiography.
bb10a31.qxd  02/05/2000  11:03  Page 3
between TM6 of TAP1 and TM4–5 of TAP2, supporting a
tail–tail orientation for the pore of TAP. The alternative
head–tail model is incompatible with these data.
Endoplasmic reticulum mobility studies indicate
head–head interactions
The biochemical data obtained above suggest that the
TAP subunits can diffuse freely within the ER membrane
to form a complex. To investigate the mobility of a multi-
spanning integral membrane molecule like TAP1(1–6),
either alone or in complex with TAP2, we made use of
GFP, a fluorescent marker protein that can be visualized
in living cells. ER mobility of TAP–GFP fusions was com-
pared with that of free GFP and of GFP coupled to a
single TM, the Type 1 signal and anchor of TAP2 [8]. 
Mobility was determined by photobleaching a small region
of the cell, which results in the irreversible inactivation of
GFP [14,15]. The recovery of fluorescence is dependent
on the movement of proteins within the plane of the mem-
brane from the area surrounding the bleached box and can
be quantitated. Figure 4a shows this for the various con-
structs. Free GFP is located within the cytoplasm and
nucleus and diffuses rapidly. GFP fused to either one or
six TMs, and thus inserted in the ER membrane, diffuses
more slowly. The mobility of GFP linked to either one
(TAP2(1)–GFP) or six TMs (TAP1(1–6)–GFP) is compa-
rable, suggesting that the molecular weight or the number
of TMs is not a major determinant of mobility. This is
consistent with theoretical models for protein diffusion in
membranes [16] as well as experimental data [17,18].
Given that the radius of the transmembrane portion of a
protein is a major determinant of its mobility in the mem-
brane [16], we tested the effect of complex formation with
excess TAP2(1–5) on the mobility of TAP1(1–6)–GFP.
Photobleaching experiments show a reduced mobility for
the complex of TAP1(1–6)–GFP and TAP2(1–5)
(Figure 4b,c, compare A and B), which is probably the
result of pore formation. To analyze which TMs of TAP2
are required for this reduction in mobility, several TAP2
derivatives were coexpressed with TAP1(1–6)–GFP.
Comparable expression levels of TAP2 derivatives were
confirmed by western blot (data not shown). The inability
of TAP2(1–4) to reduce the mobility of TAP1(1–6)–GFP
indicates that TM5 of TAP2 is involved in dimerization.
Furthermore, construct CD8–TAP2(2–5), in which TM1
is substituted with the transmembrane and extracellular
segment of CD8, is also unable to reduce the mobility of
TAP1(1–6)–GFP. These findings suggest that both the
amino- and carboxyl terminal TMs of the pore-forming
domain of TAP2 are required to change the ER mobility
of the TAP1 subunit. To test whether TM1 of TAP1 is
also involved in subunit interactions, a TAP1 derivative
with an altered TM1, Ii–TAP1(2–6), was tagged with
GFP. Addition of TAP2(1–5) had no effect on the mobil-
ity of this TAP1 construct, demonstrating that TM1 of
TAP1 is involved in the formation of a pore with reduced
mobility (Figure 4b). 
Together with the results of the post-translational transloca-
tion assays, these experiments suggest a head–head/tail–tail
orientation of the pore with direct involvement of TM1 and
TM6 of TAP1 and TM1 and TM5 of TAP2.
Discussion
Two new approaches to studying the subunit interactions
between TAP1 and TAP2 have resulted in a model for the
ABC transporter showing a head–head/tail–tail orientation
(Figure 5). Very little is known about the relative orienta-
tion of the two halves of other ABC transporters. One
study, using oxidative cross-linking between engineered
cysteine residues, supports the proximity of TM6 and 12 in
the ABC family member P-glycoprotein [19], giving a
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Figure 3
TM4 and TM5 of TAP2 are able to stabilize TM6 of TAP1(1–6),
independent of TM1 of TAP1. (a) COS cells were transfected with
pTAP1(1–6) either alone (lane 3), in combination with pTAP12(1–3)
(lane 2) or with increasing amounts of pTAP2(1–5) (lanes 4,5).
Extracts were prepared after 48 h and VSV-tagged TAP1 and TAP2
derivatives were analyzed by 12% SDS–PAGE. Proteins were
transferred to nitrocellulose and probed with anti-VSV antibodies. ECL
reactions were visualized by autoradiography. Lane 1 is the result of
endoglycosidase H (EndoH) digestion of the extract shown in lane 3.
The horizontal bar between lanes 1 and 2 indicates the position of the
29 kDa molecular-weight marker. TAP2(1–5) is marked with an arrow,
while TAP2(1–3) products run at the positions indicated with the
vertical bar. (b) COS cells were transfected with pIi–TAP1(2–6)
(lanes 1–3,5,7) and/or TAP2 derivatives as indicated at the top of the
figure and proteins were analyzed as in (a). The positions of molecular-
weight markers are indicated on the right. 
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mirror-symmetry model for the two related halves of P-gly-
coprotein analogous to the TAP model presented here.
Initially, TAP1(1–6) is inserted into the ER membrane
according to the model presented in Figure 1. In the
absence of TAP2, however, TM6 of TAP1(1–6) is unstably
embedded in the membrane. This is a unique and peculiar
feature of this construct and there is no indication that TM6
is unstable in the full-length molecule, because consensus
N-linked glycosylation sites close to TM6 and one in the
loop downstream of TM6 are not used. The complete
translocation of TM6 of TAP1 occurred both in vivo and in
vitro and does not require exogenous ATP (Figure 2c). The
binding of an antibody to the cytoplasmic tail of the mole-
cule prevents translocation. This implies that the free
carboxy-terminal glycosylation tag is transported across the
membrane post-translationally. Several proteins have been
reported to have multiple topological orientations (reviewed
in [20]), but none of these examples is the result of a post-
translational alteration. Rather, the topology is determined
by cis- and trans-acting factors during co-translational
translocation, as shown recently for the prion protein [21].
Another study reports on retrograde movement through the
translocon during the process of translation [22]. Here, gly-
cosylation or protein folding of the translocated chain could
achieve unidirectionality. This might explain the accumula-
tion of the glycosylated form of TAP1(1–6). 
The post-translational translocation has been used to
determine subunit interactions between TAP1 and TAP2.
Translocation of TM6 of TAP1(1–6) is prevented by the
expression of TM(4–5) of TAP2. Because TM1 of either
TAP1 and TAP2 is not required for this interaction to
occur, this indicates that the pore-forming segments of
TAP1 (TM1–6) and of TAP2 (TM1–5) are connected in a
tail-tail orientation. An indirect interaction between TAP1
and TAP2 is unlikely, because on purification from insect
cells, TAP behaved as a heterodimer when analyzed by
size-exclusion chromatography [23]. 
The study of the ER mobility of TAP1(1-6)–GFP fusions
has revealed further interactions between the two TAP
subunits. The crucial observation was that the association
of TAP1(1–6) and TAP2(1–5) resulted in a complex of
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Figure 4
Fluorescence recovery. (a) Fluorescence
recovery of free GFP, TAP2(1)–GFP and
TAP1(1–6)–GFP. The lines show recovery of
fluorescence in photobleached regions in the
ER of COS cells transfected with constructs
as indicated. (b) Fluorescence recovery of
TAP1(1–6)–GFP or Ii–TAP1(2–6)–GFP with
or without different TAP2 constructs.
(c) Fluorescence photobleaching recovery of
TAP1(1–6)–GFP with and without TAP2
constructs. Living COS transfectants were
analyzed by confocal microscopy at 37°C.
TAP1(1–6)–GFP shows a characteristic ER
localization: fluorescence in the nuclear
envelope and a fine reticular network. A small
region of the ER (indicated by the box) was
photobleached immediately after the first
image by scanning the region for 10 sec.
Recovery of fluorescence in the
photobleached region is shown by the images
collected after photobleaching at the times
indicated. In (A) the photobleached region of
a cell transfected with TAP1(1–6)–GFP
rapidly recovered fluorescence, whereas in
(B) the region of a cell transfected with
TAP1(1–6)–GFP and TAP2(1–5) recovered
much more slowly. Recovery in cells
transfected with TAP1(1–6)–GFP together
with TAP2(1–4) (C) or CD8–TAP2(2–5) (D)
is comparable to TAP1(1–6)–GFP only.
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lower mobility compared with the free subunit. This could
be the result of the assembly of a complex containing addi-
tional proteins, such as chaperones. It seems unlikely that
formation of a complete pore is accompanied by the associ-
ation with molecules involved in MHC class I presenta-
tion, because we (over-)express the molecules in COS cells
and furthermore, proteins like tapasin and MHC class I can
already bind to the single TAP subunits [24]. A more likely
explanation would be that the assembly of a circular pore
reduces the translational mobility of the complex because
of an increased radius. Notably, the diffusion coefficient of
a lipid embedded protein complex has been shown to be
related to the radius and not to the mass [16]. Disruption of
either head–head or tail–tail interactions does not abolish
remaining dimer interactions, but results in a complex with
a mobility comparable to the free TAP1(1–6)–GFP subunit,
because the pore is not maintained and the radius of the
transmembrane domain is reduced. 
In conclusion, the picture that has emerged for TAP is
summarized in Figure 5. The pore is composed of six
TMs of TAP1 and five TMs of TAP2 with a head–head
and tail–tail-orientation. The segments downstream of
the pore contain an additional pair of TMs that are part of
the peptide-binding domain that heterodimerizes [8] and
are located on the same side of the pore. It is possible that
ATP hydrolysis induces conformational changes that
introduce these TM doublets into the ‘closed’ pore. This
transition would then automatically open the pore and, at
the same time, position the cytoplasmic peptide-binding
domain under the opened pore. This model couples
peptide translocation to pore opening. Whereas our
model does not involve additional TM interactions in the
pore-forming domains, we can not formally exclude them.
However, the structure of P-glycoprotein at 2.5 nm reso-
lution shows a central pore consistent with a simple
head–head/tail–tail orientation [25].
Conclusions
The integral membrane pore-forming domains of the two
TAP subunits are arranged in a head–head/tail–tail orien-
tation; both the amino- and carboxy-terminal TMs are
juxtaposed in the heterodimer complex. This has impor-
tant implications for the positioning of the substrate-
binding domain that now locates to one side of the pore.
Dimer formation prevented the post-translational alter-
ation of the topology of the pore-forming domain of
TAP1. ER mobility studies can be used to study confor-
mational changes within integral membrane proteins.
Materials and methods
Transfections and extract preparation
COS-7 cells were maintained in DMEM supplemented with 7.5% fetal
calf serum. Transfections were performed using the DEAE–dextran
method. Cells were harvested in PBS, cell pellets lysed in 50 mM Tris
pH 7.5, 1 mM EDTA, 150 mM NaCl, 1% NP-40 (TEN/NP40) on ice for
30 min. Digestion with endoglycosidase H (Boehringer, Mannheim) was
done at 50 µU/µl for 3 h at 37°C in lysis buffer supplemented with 0.2%
SDS and 1 mM phenylmethansulfonyl fluoride (PMSF). Membranes were
prepared as described [8].
DNA constructs
Truncations of TAP1 and TAP2 have been generated in which the car-
boxyl terminal amino acid is used to name the construct [8]. Plasmid
B1.G247 was obtained by cloning the XbaI fragment of pTAP1–G247
into pBluescript. pTAP(1–6) is equivalent to pTAP1–G247. Similarly,
pTAP2(1–5) is identical to pTAP2–R210, pTAP2(1–4) to pTAP2–R175
and pTAP2(1–3) to pTAP2–E128. pTAP2(4–5) was obtained by stan-
dard PCR technology using a 5′ primer to start at amino acid S120 in
combination with 3′ primer R210 and subsequent cloning into the SalI-
site of pMT2IiVSV [8]. 
pTAP1(1–6)–GFP was obtained by cloning the SalI fragment of
pTAP1–H257 into pEGFP–N3 (Clontech). pTAP2(1) was obtained by
cloning the SalI–NotI fragment of pTAP2–R45 into pEGFP–N3. pIi-
TAP1(2–6)–GFP was obtained by cloning the PstI–SalI fragment
obtained after a partial PstI-digestion of pIi-TAP1(2–6) into pEGFP–N3. 
In vitro transcription and translation
RNA was prepared from pB1.G247 linearized with SacI according to
the protocol provided by Promega. In vitro translations were performed
as suggested by the manufacturer in rabbit reticulocyte lysates supple-
mented with microsomes prepared from dog pancreas (Promega) and
[35S]methionine/cysteine (Amersham, 10 mCi/ml). After a 15 min pulse
at 30°C, lysates were cooled to 4°C and membranes were pelleted for
20 min at 14,000 rpm, washed with ice-cold PBS, and chased in PBS
at 30°C for the times indicated. Antibodies (1 µl; anti-VSV-G–peroxi-
dase or anti-Myc–peroxidase, Boehringer) was added per 0.5 µl micro-
somes during the chase.
Pulse–chase experiments
COS-7 cells were starved for 30 min, 48 h after transfection with
pTAP1–G247, in Met/Cys-free RPMI medium including 10% FCS fol-
lowed by labeling the cells with 80 µCi [35S]Met/Cys for 15 min. The
pulse was stopped by addition of non-radioactive Met/Cys to a final
concentration of 1 mM. After culturing for various times, cells were lysed
in lysis mixture and the TAP species were immunoprecipitated with the
anti-VSV antibody P5D4 prior to analysis by 12% SDS–PAGE.
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Figure 5
Model of the TAP heterodimeric complex. The TAP complex consists
of three domains: a transmembrane pore in a head–head/tail–tail
orientation, a peptide-binding domain and the nucleotide-binding
domain (shown here as ATP). The peptide-binding segment is made
up of interacting segments from the two subunits, is anchored in the
ER membrane by two TM doublets and is located between the pore
region and the two nucleotide-binding domains (see also [8]). The
tail–tail orientation positions these segments to one side of the pore.
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Confocal analysis and photobleaching
Living cells were analyzed in a tissue-culture device at 37°C using a
600MRC confocal microscope equipped with an argon/krypton laser
(BioRad Labs, Hercules, CA). Green fluorescence was detected at
λ > 515 nm after excitation at λ = 488 nm. To bleach GFP-tagged
TAP1(1–6) in living cells, a small region of the ER was scanned for 10 sec. 
Fluorescence recovery after photobleaching
To investigate mobility of GFP-tagged TAP1(1–6), fluorescence recov-
ery after photobleaching (FRAP) experiments were performed [14,15].
A box in the ER was photobleached and the effect on the fluorescence
in this box versus a box in the ER outside the bleached region was
quantitated. From these data, recovery of fluorescence by diffusion of
unbleached GFP-tagged TAP1(1–6) after bleaching can be deter-
mined using the formula % recovery = (FA after + FB before – FB
after)/(FA before). FA is the fluorescence in the bleach box and FB the
fluorescence in the box outside this region. The fluorescence is deter-
mined before and after photobleaching, and both FA and FB will
decrease slightly due to equal photobleaching of the complete cell
during imaging.
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